Transcatheter aortic valve implantation (TAVI) is the principal therapeutic option in patients with severe aortic stenosis considered inoperable or at high risk for open-heart surgery. Thus has progressively increased the rates of its use with this indication. Increasing evidence point towards the effectiveness of TAVI in patients considered at intermediate or even at low surgical risk.
Stroke is an unpredictable complication during and after TAVI with potential devastating outcomes. Clinically silent lesions are detected by MRI in the majority of the TAVI patients and may be associated with cognitive impairment. Case: A 64 year old female with hypertension and recent cerebrovascular event with thickened, calcified severe aortic stenosis-Sevier’s I Bicuspid AVA 0.4 cm2; totally occluded right internal carotid artery (ICA) and occluded right subclavian artery with excellent left to right…
